Published 05-23-12
Submitted by BD - Becton, Dickinson and Company
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today the publication of its 2011 Sustainability Report. The report focuses on the Company’s shared-value approach to sustainability, which focuses on the relationship among strong economic performance, social responsibility and respect for the environment.
"We are pleased to report on BD’s progress in achieving our sustainability goals, as well as how we are addressing the many challenges we face in the global business environment," said Vincent A. Forlenza, Chief Executive Officer and President. "We are broadening and redefining our approach to products, markets, services, productivity and even associate engagement, to drive higher shared value as well as higher shareholder value.”
This year, BD’s reporting aligns more closely with version 3.1 of the Global Reporting Initiative (GRI) guidelines, and the Company has self-assessed the new report at GRI application level B. BD’s 2011 Sustainability Report highlights strategic priorities and performance in areas including:
The new report also highlights the many awards and recognitions that BD received in 2011 in the areas of sustainability, innovation, employer of choice, and environment, health and safety, including:
To view the full BD 2011 Sustainability Report online, visit www.bd.com/sustainability.
About BD
BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit www.bd.com.
BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people's health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public.
More from BD - Becton, Dickinson and Company